Acute myocardial infarction stem cell therapy(Cytopeutics)

N/A

Report date: 2023/01/08 14:03:56

Base Information

Drug NameAcute myocardial infarction stem cell therapy(Cytopeutics)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsCardiomyopathy, Dilated
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCytopeutics Sdn Bhd
China Registration ClassN/A

Develop Information

Active CompaniesCytopeutics Sdn Bhd
Inactive CompaniesN/A
Active IndicationsCardiomyopathy, Dilated
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A